A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome
Clinical trial NCT01325740 · SUSPENDED
Trial details
- NCT number
- NCT01325740
- Sponsor
- Seaside Therapeutics, Inc.
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-09-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.